The firm served as lead counsel on behalf of Oklahoma Medical Research Foundation in a patent infringement suit brought in the Northern District of Oklahoma against Alexion Pharmaceuticals. The patents related to complement-inhibition technology and their use in a drug marketed by Alexion to treat a rare, debilitating and life-threatening disease. After replacing OMRF’s previous counsel in the matter and soon after claim construction briefing was complete, we obtained a settlement. It included payment to our client as well as public acknowledgement that individuals affiliated with OMRF were the true inventors of the technology at issue.

Oklahoma Med. Research Found. v. Alexion Pharmaceuticals, Inc., No. 07-163 (N.D. Okla. filed Mar. 15, 2007).

Experience Center

Match our Experience to Your Needs

Experience Highlights

Bankruptcy case for one of the largest bank holding companies located in Georgia
Assisted one of the largest bank holding companies located in Georgia as the secured party lender in recovery of multiple properties that served as more
Pennington Seed, Inc. & Pennington Seed of Nebraska, Inc. v. United Industries Corp., d/b/a Spectrum Brands
Represented United Industries Corporation (d/b/a Spectrum Brands) in trademark litigation against a competitor and successfully settled the matter more
Joint venture for WebMD
Represented WebMD, in connection with the international aspects of a $1 billion joint venture with NewsCorp. more
Electronic health records for a national beverage manufacturer
Assist a national beverage manufacturer in designing electronic health records for its employee group health plan. more